Currently out of the existing stock ratings of Zhiqiang Shu, 18 are a BUY (72%), 7 are a HOLD (28%).

Zhiqiang Shu

Work Performance Price Targets & Ratings Chart

Analyst Zhiqiang Shu works with a stock forecast success ratio of 33.33% fulfilled within 45.22 days on average. Previously, Zhiqiang Shu worked at BERENBERG.

Zhiqiang Shu’s has documented 44 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 13-Sep-2023.

Wall Street Analyst Zhiqiang Shu

Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 11/12/2021. The price target of $11 was fulfilled within 6 days with a profit of $0.68 (5.82%) receiving and performance score of 9.7.

Average potential price target upside

BLUE Bluebird bio SNSE Sensei Biotherapeutics STRO Sutro Biopharma BPMC Blueprint Medicines Corp PNT POINT Biopharma Global KRON Kronos Bio  SGEN Seagen AFMD Affimed NV SRPT Sarepta Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

3

$1.97 (191.26%)

5

1 months 29 days ago

2/5 (40%)

$1.63 (118.98%)

178

Hold

6

$4.97 (482.52%)

8

1 months 29 days ago

1/5 (20%)

$4.63 (337.96%)

24

Buy

7

$5.97 (579.61%)

10

5 months 14 days ago

0/2 (0%)

$4.21 (150.90%)

Buy

12

$10.97 (1065.05%)

11

5 months 15 days ago

1/8 (12.5%)

$8.93 (290.88%)

184

Buy

13

$11.97 (1162.14%)

10

6 months 18 days ago

4/7 (57.14%)

$9.74 (298.77%)

106

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Zhiqiang Shu?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?